Endeavor
40 article(s) found
![](/contentassets/27a4f65299784345b20535dc5f74420f/mdrum_cancer_under_attack-4-1400.jpg)
FDA Set to Approve Earlier Use of CAR T for Multiple Myeloma
![](/contentassets/c4c13d133ba749d19d9d854db0bb1c0d/tandem-hero1.jpg)
Is Outpatient CAR T Therapy Safe for Multiple Myeloma Patients?
![](/contentassets/c371497a6048486a9ba7d74ebc506886/berlin-1440.jpg)
Victory Over Adversity
![](/contentassets/5bd6700024a34edba1b5a6578090477c/pfacblankets-1440.jpg)
Spreading the Warmth of Holiday Cheer
![](/contentassets/cffeea2c7b92454090d153c09ccea37d/ash-multipe-myeloma-1400.jpg)
Identifying Inflammatory Markers Related to Toxicities Early Can Improve Multiple Myeloma Treatment
![](/contentassets/1e19ef5e624b4992ba96a419d6b734b7/representation-matters-1440.jpg)
For Patients and Profession, Representation Matters
![](/contentassets/dba1baf2b8bf472b9410b88daf880e15/nyc-recap-hero.jpg)
Are Cellular Therapies the New Frontier in Cancer Treatment?
![](/contentassets/162e3b2fcc8b4fda9eb415511cfb30dd/larry-parker-1400.jpg)
Patient Marks Moffitt’s 1,000th CAR T Treatment
![](/contentassets/fd7d952fdb164970b5a4cc7a1cd21e85/blood-cells-1440.jpg)
Moffitt Researchers Target Cellular Process to Improve Multiple Myeloma Outcomes